According to recent experimentation in pancreatic cancer, DNMT1 exerts repressive effects on miR‐34a expression while concurrently promoting the activation of the Notch pathway through mediation of the hypermethylation process targeting the miR‐34a promoter region. Here, DNMT1 is linked to pancreatic neoplasm.